Dow Down 0.41% Nasdaq Up 0.48%

Neurocrine Biosciences Inc. (NBIX)

-NasdaqGS
16.55 Up 0.23(1.38%) 10:04AM EDT - Nasdaq Real Time Price
Prev Close:16.32
Open:16.29
Bid:16.48 x 100
Ask:16.54 x 400
1y Target Est:22.67
Beta:-0.42
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:16.29 - 16.74
52wk Range:8.57 - 20.29
Volume:56,533
Avg Vol (3m):534,209
Market Cap:1.26B
P/E (ttm):N/A
EPS (ttm):-0.67
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NBIX

Comparison

Symbol% ChgMkt Cap
NBIXUp 1.38%1.26B
ABTUp 0.27%61.61B
LLYUp 0.05%67.10B
PFEDown 0.25%176.02B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):849.21
Ex-Dividend Date:29-Dec-95

Analysts

Annual EPS Est (Dec-14) :-0.81
Quarterly EPS Est (Sep-14) :-0.21
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-1.61

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neurocrine Biosciences, Inc. discovers, develops, and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback